MAY 09, 2017 07:00 AM PDT

WEBINAR: Advanced assays for high-throughput assessment of ion channel inhibition and cardiac toxicity

SPONSORED BY: Molecular Devices
C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Field Applications Scientist, Molecular Devices
    Biography
      Beiyan Zou is a Field Applications Scientist at Molecular Devices supporting reagents, FlexStation3, FLIPR and automated electrophysiology platforms. She received a Ph.D. degree in Biology at Pennsylvania State University and completed postdoctoral training in the Department of Neuroscience at John Hopkins University School of Medicine. She has 18 years of experience in molecular biology/genetics, 8 years of experience in ion channel biology, 4 years of experience in cellular imaging, and 8 years of experience in assay development and high throughput screen including 5 years of experience as a project leader at the Johns Hopkins Ion Channel Center, one of the nine NIH roadmap program funded screening centers. She has authored and coauthored in 20 peer-review papers in prestigious journals including PNAS, Cell, Journal of Neuroscience, Molecular Pharmacology and Assay Drug Development Technologies.
    • Senior Research Scientist at Molecular Devices,LLC
      Biography
        Oksana Sirenko is a Senior Research Scientist at Molecular Devices working on development of new technologies for imaging and high content analysis. Oksana also has previous experience working on drug discovery and drug development at several biotech companies in San Francisco Bay Area. The focus of her current scientific research is on development methods for high throughput in vitro toxicity screening, including 3D models. Oksana has a PhD in Biochemistry and B.S. in Biology.

      Abstract:

      DATE: May 9th, 2017
      TIME: 7:00AM PDT, 10:00AM ET, 2:00PM GMT

       

      Early detection and elimination of new chemical entities with cardiac or hERG liability could substantially improve drug safety and minimize the cost of development. In this webinar, we will highlight different assays for validating ion channel inhibition using cell lines and cardiac toxicity using induced pluripotent stem cells (iPSCs).

      High-throughput screening for in vitro potency evaluation of cardiac ion channel inhibitors on the FLIPR Tetra® System

      Learning Objectives:

      • Optimize and validate a robust cell-based hERG fluorescence assay using the FLIPR® Potassium Assay Kit, a thallium-sensitive fluorescence dye to directly measure ion influx
      • Run inhibition assays with voltage-gated sodium channels (NaV1.5) and L-type voltage-gated calcium channels (CaV1.2) using FLIPR® Membrane Potential Dye and FLIPR® Calcium 6 Dye, respectively
      • Demonstrate high-throughput, early stage in vitro compound and potency assessment with comparable results from electrophysiological recording data

       

      Multi-parameter in vitro assessment of compound effects on cardiomyocyte physiology using induced pluripotent stem cells

      Learning Objectives:

      • Determine the effects of pharmacological compounds and other chemicals on the beating rate and profiles of cardiomyocytes using the FLIPR Tetra system and ImageXpress® Micro system. Assay data is characterized from 2D and 3D spheroid cardiomyocyte cultures. The assays employ calcium sensitive dyes to monitor changes in intracellular Ca2+ fluxes synchronous with cell beating which allows monitoring of beat rate, amplitude, and other parameters.
      • Identify methods for multiparametric analysis and ranking of compounds for potential cardiotoxic hazards. This methodology is well suited for testing environmental chemicals and early safety testing in drug development prior to clinical studies.

       


      Show Resources
      You May Also Like
      JUN 05, 2019 05:00 PM CEST
      C.E. CREDITS
      JUN 05, 2019 05:00 PM CEST
      DATE: June 5, 2019TIME: 8:00am PDT, 11:00am EDT, 5:00pm CEST Eukaryotic cell cultures respond to the most subtle influence. Apart from the risk of contamination, minimal chan...
      NOV 18, 2019 07:00 AM PST
      C.E. CREDITS
      NOV 18, 2019 07:00 AM PST
      DATE: November 18, 2019TIME: 7:00am PST, 11:00am EST, 4:00pm CEWT How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop th...
      JUN 19, 2019 10:00 AM PDT
      JUN 19, 2019 10:00 AM PDT
      DATE: June 19, 2019TIME: 10:00am PDT, 1:00pm EDT As we develop new methods to create more biologically relevant models for research in understanding disease etiology and in...
      AUG 27, 2019 09:00 AM PDT
      C.E. CREDITS
      AUG 27, 2019 09:00 AM PDT
      DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
      OCT 02, 2019 11:00 AM PDT
      OCT 02, 2019 11:00 AM PDT
      DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
      SEP 05, 2019 04:00 PM CEST
      C.E. CREDITS
      SEP 05, 2019 04:00 PM CEST
      DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
      Loading Comments...
      Show Resources